Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus

OBJECTIVE: This study aimed to evaluate ertugliflozin in patients with overweight and obesity with type 2 diabetes mellitus. METHODS: Data from three placebo‐controlled, randomized, Phase 3 studies were pooled. Patients with baseline BMI ≥ 25 (1,377/1,544; 89%) were assessed with a stratification by...

Descripción completa

Detalles Bibliográficos
Autores principales: Heymsfield, Steven B., Raji, Annaswamy, Gallo, Silvina, Liu, Jie, Pong, Annpey, Hannachi, Hakima, Terra, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217180/
https://www.ncbi.nlm.nih.gov/pubmed/32202075
http://dx.doi.org/10.1002/oby.22748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217180/
https://www.ncbi.nlm.nih.gov/pubmed/32202075
http://dx.doi.org/10.1002/oby.22748

Ejemplares similares